(239 days)
Not Found
No
The device description and intended use focus on the physical properties and composition of a wound dressing, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes
This device is a medical dressing intended for wound healing, which falls under the definition of a therapeutic device.
No
The device is a wound dressing designed to provide a moist environment for wound healing, not to diagnose medical conditions.
No
The device is a wound dressing comprised of physical materials (honey, emulsifier, surfactant) and is not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description and Intended Use: The description clearly states that the Medihoney Gel Dressings are wound care dressings applied directly to the wound surface. Their intended use is to provide a moist environment for wound healing and manage various types of wounds.
- No Mention of In Vitro Testing: The text does not mention any testing of samples taken from the body or any diagnostic purpose. The focus is entirely on the topical application and effect on the wound itself.
Therefore, the Medihoney Gel Dressings with Active Manuka Honey are a medical device (specifically, a wound dressing), but not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Derma Sciences Medihoney Gel Dressings with Active Manuka Honey provide a moist environment conducive to wound healing and are indicated for light to moderately exuding wounds.
For over the counter use, Medihoney Gel Dressings with Active Manuka Honey may be used for:
- minor abrasions -
- lacerations -
- minor cuts
- minor scalds and burns
Under the supervision of a healthcare professional, The Derma Sciences Medihoney Gel Dressings provide a moist environment conducive to wound healing and are indicated for light to moderate exuding wounds. The Medihoney Gel Wound Dressings are intended for the management of the following:
- diabetic foot ulcers .
- leg ulcers (venous stasis ulcers, arterial ulcers and leg ulcers of mixed etiology) .
- pressure ulcers / sores (partial and full thickness) ●
- 1st and 2nd degree partial thickness burns .
- donor sites, and traumatic and surgical wounds. .
Product codes
FRO
Device Description
Derma Sciences Medihoney Gel Dressings with Active Manuka Honey are sterile, wound care dressings for use in moist wound management. The Derma Sciences Medihoney Gel Dressing with Active Manuka Honey is offered in 10, 20, and 25 oz tubes sizes. The dressings are comprised of honey an emulsifier and a surfactant.
The proposed Medihoney Gel Dressing with Active Manuka Honey contains Active Manuka Honey. As wound exudate is absorbed, the alginate forms a gel, which assists in maintaining a moist environment that aids supports the autolytic debridement for optimal wound healing.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Over-the-Counter Use and supervision of a healthcare professional
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility testing performed to support the formulation change for the modified dressings demonstrates that the Medihoney Gel Dressings with Active Manuka Honey are safe for their intended use. The biocompatibility testing included cytotoxicity, implantation, sensitization, and irritation testing (repeat patch insult testing).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K081584, K080315, K072956, K053095
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
N/A
0
Page 1 of 3
FEB 2 2 2011
510(k) Summary for Derma Sciences Medihoney Gel Dressings with Active Manuka Honey
- SPONSOR
Kam Garcha Derma Sciences, Inc. 104 Shorting Road Toronto, Ontario MIS 3S4 Canada 416-299-4003 Telephone:
Date Prepared: June 23, 2010
2. DEVICE NAME
Derma Sciences Medihoney Gel Dressing with Active Proprietary Name: Manuka Honey Wound Dressing Common/Usual Name: Classification Name: Dressing
3. PREDICATE DEVICES
- · Derma Sciences OTC Medihoney Dressings with Active Manuka Honey (K081584)
- · Derma Sciences Medihoney Dressing with Active Manuka Honey (K080315)
- · Medihoney Primary Wound Dressings with Active Manuka Honey (K072956)
- · API-MED Active Manuka Honey Wound Dressings (K053095)
4. DEVICE DESCRIPTION
Derma Sciences Medihoney Gel Dressings with Active Manuka Honey are sterile, wound care dressings for use in moist wound management. The Derma Sciences Medihoney Gel Dressing with Active Manuka Honey is offered in 10, 20, and 25 oz tubes sizes. The dressings are comprised of honey an emulsifier and a surfactant.
The proposed Medihoney Gel Dressing with Active Manuka Honey contains Active Manuka Honey. As wound exudate is absorbed, the alginate forms a gel, which assists in maintaining a moist environment that aids supports the autolytic debridement for optimal wound healing.
1
5. INTENDED USE
The Derma Sciences Medihoney Gel Dressings with Active Manuka Honey provide a moist environment conducive to wound healing and are indicated for light to moderately exuding wounds.
For over the counter use, Medihoney™ Gel Dressings with Active Manuka Honey may be used for:
- minor abrasions
- lacerations
- minor cuts
- minor scalds and burns
Under the supervision of a healthcare professional, The Derma Sciences Medihoney Gel Dressings provide a moist environment conducive to wound healing and are indicated for light to moderate exuding wounds. The Medihoney Gel Wound Dressings are intended for the management of the following:
- · diabetic foot ulcers
- · leg ulcers (venous stasis ulcers, arterial ulcers and leg ulcers of mixed etiology)
- · pressure ulcers / sores (partial and full thickness)
- · 1st and 2nd degree partial thickness burns
- · donor sites, and traumatic and surgical wounds.
6. TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE
The technological characteristics of the Derma Sciences Medihoney Gel Dressings with Active Manuka Honey and the parent Medihoney Wound Dressings with Active Manuka Honey are substantially equivalent in that they are all honey based dressings suitable for use on pressure sores, leg ulcers, post-operative wounds, superficial wounds and abrasions. In addition, both the proposed and predicate devices are intended for both OTC and prescription use.
The modifications made to the Medihoney Wound Dressings with Active Manuka Honey Dressings to produce the Derma Sciences Medihoney Gel Dressings with Active Manuka Honey are limited to a slight change in formulation. The proposed Medihoney Gel Wound Dressings with Active Manuka Honey are comprised of 80%
2
K101793
Active Manuka Honey, 15% Myristyl Myristate and 5% Plantacare 810 compared to the parent Medihoney Primary Dressings which are comprised of 100% honey, 80% Active Manuka Honey and 20% sodium alginate powder or 95% w/w Active Manuka Honey and 5% w/w Calcium Alginate. The addition of the Myristyl Myristate and Plantacare 810 increases the viscosity of the gel which helps to improve adherence to the wound bed. This slight change in formulation provides the user with a wider variety of honey dressings and does not represent a significant change in technological
The intended use of the Derma Sciences Medihoney Gel Dressings with Active Manuka Honey and the predicate devices are identical in that they are all intended to provide a moist environment conducive to wound healing. The Derma Sciences Medihoney Gel Dressings with Active Manuka Honey are identical to the parent Medihoney Dressing in indications in that they are both indicated for management of light to moderately exuding wounds including partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions, and Stage I-IV dermal ulcers (vascular, venous, pressure and diabetic).
7. PERFORMANCE TESTING
Biocompatibility testing performed to support the formulation change for the modified dressings demonstrates that the Medihoney Gel Dressings with Active Manuka Honey are safe for their intended use. The biocompatibility testing included cytotoxicity, implantation, sensitization, and irritation testing (repeat patch insult testing).
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle. The logo is black and white.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Derma Sciences, Inc. % Medical Device Consultants, Inc. Mr. Ronald S. Warren 49 Plain Street North Attleboro, Massachusetts 02760
FEB 2 2 251
Re: K101793
Trade/Device Name: Derma Sciences Medihoney Gel Dressings with Active Manuka Honey Regulatory Class: Unclassified Product Code: FRO Dated: January 17, 2011 Received: January 19, 2011
Dear Mr. Warren:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
4
Page 2 - Mr. Ronald S. Warren
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours
Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
K101793
page 1 of 1
Indications for Use
510(k) Number (if known):
Device Name: Derma Sciences Medihoney Gel Dressings with Active Manuka Honey
K 101793
Indications for Use:
The Derma Sciences Medihoney Gel Dressings with Active Manuka Honey provide a moist environment conducive to wound healing and are indicated for light to moderately exuding wounds.
For over the counter use, Medihoney Gel Dressings with Active Manuka Honey may be used for:
- minor abrasions -
- lacerations -
- minor cuts
- minor scalds and burns
Under the supervision of a healthcare professional, The Derma Sciences Medihoney Gel Dressings provide a moist environment conducive to wound healing and are indicated for light to moderate exuding wounds. The Medihoney Gel Wound Dressings are intended for the management of the following:
- diabetic foot ulcers .
- leg ulcers (venous stasis ulcers, arterial ulcers and leg ulcers of mixed etiology) .
- pressure ulcers / sores (partial and full thickness) ●
- 1st and 2nd degree partial thickness burns .
- donor sites, and traumatic and surgical wounds. .
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-the-Counter Use × (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Da-l. Kume bu MXM
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K101793